Research and Markets (http://www.researchandmarkets.com/research/hbb5t3/melanoma) has announced the addition of the "Melanoma - Pipeline Review, 2015" report to their offering.The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Melanoma diagnostic tests pipeline products.Scope

  • Extensive coverage of the Melanoma diagnostic tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Melanoma diagnostic tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Key Topics Covered:1 Tables & Figures2 Introduction3 Products under Development4 Melanoma - Pipeline Products under Development by Companies5 Melanoma Companies and Product Overview6 Melanoma- Recent Developments7 AppendixCompanies Mentioned

  • Abbott Diagnostics
  • Adaptive Biotechnologies Corporation
  • Advanced Cell Diagnostics, Inc.
  • Agilent Technologies, Inc.
  • BioMarker Strategies, LLC
  • Biosceptre (Aust) Pty Ltd
  • Boston University
  • Ceres Nanosciences, Inc.
  • Dana-Farber Cancer Institute, Inc.
  • Digna Biotech, S.L.
  • Exosomics Siena SpA
  • Genomic Health, Inc.
  • Hospital Universitario Cruces
  • HTG Molecular Diagnostics, Inc.
  • ImmunID Technologies
  • InterGenetics Incorporated
  • IV Diagnostics, Inc.
  • Louisville Bioscience, Inc.
  • MDNA Life Sciences, Inc.
  • Melanovus Oncology, Inc.
  • MolecularMD, Corp.
  • Myriad Genetics, Inc.
  • Orion Genomics LLC
  • Oryzon Genomics S.A.
  • Pacific Edge Limited
  • Qiagen N.V.
  • Roche Diagnostics International Ltd.
  • Rosetta Genomics, Ltd.
  • Sividon Diagnostics GmbH
  • SomaLogic, Inc.
  • The Johns Hopkins University
  • Zymera, Inc

For more information visit http://www.researchandmarkets.com/research/hbb5t3/melanoma

Research and MarketsLaura Wood, Senior Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Sector: In Vitro Diagnostics, Skin Cancer